Bucharest, Romania

Corina-Mihaela Manta

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Corina-Mihaela Manta: Innovator in Therapeutic Compounds

Introduction

Corina-Mihaela Manta is a notable inventor based in Bucharest, Romania. He has made significant contributions to the field of therapeutic compounds, particularly in the development of salts and esters of APX3330. His work focuses on innovative solutions for treating various diseases.

Latest Patents

Corina-Mihaela Manta holds a patent for "Salts and esters of APX3330 and therapeutic uses thereof." This invention relates to Compound 1 (APX3330) salts and esters. The patent also provides compositions comprising a Compound 1 salt or ester. Furthermore, it includes compounds of formula (I) and formula (II) and pharmaceutically acceptable salts thereof. The invention outlines methods for treating or preventing diseases such as cancer, liver disorders, ocular disorders, cardiovascular disorders, fibrosis, or inflammatory disorders. This is achieved by administering an effective amount of a Compound 1 salt or ester, or a compound of formula (I) or formula (II), or pharmaceutically acceptable salt thereof.

Career Highlights

Corina-Mihaela Manta is currently associated with Opus Genetics, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic applications.

Collaborations

He collaborates with esteemed colleagues, including Daniela Carmen Oniciu and Anthony Carestia, who contribute to his innovative projects and research endeavors.

Conclusion

Corina-Mihaela Manta is a distinguished inventor whose work in therapeutic compounds holds promise for addressing critical health challenges. His contributions to the field are noteworthy and continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…